Skip to main content
HR 4702 118th Congress House Health Administrative law and regulatory procedures Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Genetics Health technology, devices, supplies Medical research Research administration and funding

Securing Gene Synthesis Act

Introduced: July 18, 2023 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2023
Referred to the Subcommittee on Health.
Jul 18, 2023
Referred to the House Committee on Energy and Commerce.
Jul 18, 2023
Introduced in House
 Plain-English summary Congressional Research Service

Securing Gene Synthesis Act

This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.

What's happening now July 21, 2023

Referred to the Subcommittee on Health.

 Committees of jurisdiction 2